Li WANG, Yan JIN, Chao JIANG, et al. Specific PCR Method for Identification of Suis FellisPulvis and Its Chinese Patent Medicines[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(17): 136-141.
DOI:
Li WANG, Yan JIN, Chao JIANG, et al. Specific PCR Method for Identification of Suis FellisPulvis and Its Chinese Patent Medicines[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(17): 136-141. DOI: 10.13422/j.cnki.syfjx.20191714.
Specific PCR Method for Identification of Suis FellisPulvis and Its Chinese Patent Medicines
A polymerase Chain reaction(PCR) identification method for Suis Fellis Pulvis and its Chinese patent medicines was established to provide an example for the identification of animal-derived components in complex components.
Method:
2
A PCR identification method was established based on swine derivatives identification primers
the reaction system was optimized
and the established method was investigated and verified. By the established PCR identification method
the swine derivatives of 20 batches of self-made Suis Fellis Pulvis material
19 batches of commercially available Suis Fellis Pulvis and 22 batches of Chinese patent medicines containing Suis Fellis Pulvis were identified. The commercially available Suis Fellis Pulvis material and Chinese patent medicines containing Suis Fellis Pulvis positive products that were amplified PCR were verified by enzyme digestion and sequencing.
Result:
2
Totally 20 batches of self-made Suis Fellis Pulvis material and Suis Fellis Pulvis control material could expand the specific identification band of about 212 bp
and there was no bands in bovine and ovine reference
only 5 batches of the 19 batches of commercially available Suis Fellis Pulvis had expanded specific identification bands
10 batches of 22 batches of Chinese patent medicines containing Suis Fellis Pulvis were detected to have swine derivatives
the Suis Fellis Pulvis control material and the PCR-amplified commercially available Suis Fellis Pulvis material positive products can produce about 200 bp of bands after digestion with
Mnl
I. The highest similarity between the amplification products sequence of Suis Fellis Pulvis and its Chinese patent medicines
and the GenBank database was
Sus scrofa
the consistency was 99%
which conformed to the sequence of swine.
Conclusion:
2
The PCR identification method established in this paper can accurately identify the biological origin of Suis Fellis Pulvis and its Chinese patent medicines.
Kwon K R , Baek S I , Choi S H . Identification of Fel ursi and Cattle and Pig Bile Juicesby species-specific PCR and PCR-RFLP [J]. J Pharmacopunct , 2009 , 12 ( 1 ): 13 - 20 .
Meta-analysis and Grade Evidence Evaluation of Qi-reinforcing and Blood-activating/ Stasis-expelling Chinese Patent Medicines in Treatment of Coronary Microvascular Disease
Interpretation of Reporting Items for Practice Guidelines in Healthcare for Chinese Patent Medicines (RIGHT for CPM)
Clinical Comprehensive Evaluation of Chinese Patent Medicines in Treatment of Stable Angina Pectoris with Qi Stagnation and Blood Stasis
GRADE Clinical Study Evidence Evaluation and Expert Consensus on Antihypertensive Chinese Patent Medicines Combined with Western Medicines for Treatment of Hypertension
Evaluation of GRADE Clinical Research Evidence of Chinese Patent Medicine Combined with Western Medicine in Treatment of Hypertension with Dyslipidemia
Related Author
CHEN Jiaping
SHANG Juju
LIU Hongxu
LI Xiang
LAI Xiaolei
ZHOU Huiwen
WANG Liaoyao
PAN Hejing
Related Institution
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Center for Evidence-based Medicine, Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
School of Basic Medical Sciences, Zhejiang Chinese Medical University
The Affiliated Hospital of Traditional Chinese Medicine, Xinjiang Medical University